Centene vs Illumina

Centene (CNC), health care, and Illumina (ILMN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Centene is worth $35.9B on the stock market and Illumina $30.6B: Centene is valued at 17% more. Centene trades at 24.9 times earnings and Illumina at 34.9; operating margins in their latest fiscal years were -3.91% and 18.6%. Over the past year Centene's share price has moved +102% and Illumina's +62.3%.

Key facts

Centene market value
$35.9B
Illumina market value
$30.6B
Centene P/E
24.9
Illumina P/E
34.9
Centene revenue
$194.8BFY to 2025-12-31
Illumina revenue
$4.3BFY to 2025-12-28
Superinvestors holding both
3

Market values as of .

Centene vs Illumina: every measure side by side
Measure Centene Illumina
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-28
Size
Market cap$35.9Bhigher$30.6Blower
Revenue$194.8Bhigher$4.3Blower
Earnings-$6.7Blower$850Mhigher
Employees61,100higher8,600lower
Total assets$76.7Bhigher$6.6Blower
Valuation
P/E24.9lower34.9higher
P/S0.2lower7.1higher
P/B1.6lower9.8higher
Dividend yield0.00%0.00%
Profitability
Operating margin-3.91%lower18.6%higher
Balance sheet
Net assets$20Bhigher$2.7Blower
Total liabilities$56.7Bhigher$3.9Blower
Total debt$17.5B—
Cash on hand$17.9Bhigher$1.4Blower
Price change
Today-2.97%lower+2.33%higher
1 year+102%higher+62.3%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Centene / Illumina). Who owns CNC · Who owns ILMN

Further comparisons

Learn

Questions and answers

Which is bigger, Centene or Illumina?

By market value, Centene is the larger: $35.9B against $30.6B for Illumina. By revenue in its latest fiscal year, Centene is the larger: $194.8B against $4.3B for Illumina.

Which has the higher P/E ratio?

Illumina: 34.9, against 24.9 for Centene. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Illumina: 18.6%, against -3.91% for Centene. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Centene and Illumina?

In their latest 13F filings, Cliff Asness, Jim Simons (1938–2024) and Diamond Hill team hold both.

Cite this page

Funkfolio, “Centene vs Illumina”, data as of 17 November 2026. https://funkfolio.com/compare/cnc-vs-ilmn

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.